Evaran
PrivateLast Round
Series A
Aug 1, 2021
Est. Valuation
$17.68M
Total Funding Raised
$6.27M
Company Overview
Evaran operates in Healthcare & Life Sciences and is based in Melbourne. Its latest recorded funding round was a Series A round in August 2021.
Evaran is a software company that provides a unified care technology platform for residential and home aged care providers and retirement living operators.
Sector
Healthcare & Life Sciences
Verticals
Vertical SaaS, EHR & EMR, Compliance & Risk
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Evaran Comparables
Compare Evaran with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CareVision | 84% | |
| OneTouch Health | 83% | |
| Leecare Solutions | 80% |
For institutional investors. Book with your work email.
Evaran Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Aug 1, 2021 | ||||
| Seed | Oct 1, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Evaran Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DSC Investment | Series A |
| NAVER D2SF | Seed |
| Shinhan Financial Group | Series A |
| Samsung Venture Investment | Seed, Series A |
| ETRI Holdings | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 1, 2019
$1.5M raised from NAVER D2SF and Samsung Venture Investment.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- hiresSep 28, 2026
On Sep 28th '26, Evaran appointed James Frampton as its UK general manager to help guide its strategic direction and drive growth across its UK operations.
For institutional investors. Book with your work email.
Evaran Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Evaran's valuation, stock price, and market status.
Is Evaran a public or private company?
Evaran is a private company.
What is the current stock price of Evaran?
Evaran is a private company, so its shares have no public market price. Caplight tracks Evaran's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Evaran worth (valuation)?
Evaran's valuation is estimated at $17.7M based on funding round data.
Can I buy Evaran stock?
Evaran shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Evaran's last funding round?
Evaran's most recent funding round was Series A on August 1, 2021.
Who are the main investors in Evaran?
Key investors in Evaran include DSC Investment, NAVER D2SF, Shinhan Financial Group, Samsung Venture Investment, ETRI Holdings.
Will Evaran IPO soon?
No public IPO plans have been announced for Evaran.
How can I track Evaran secondary market activity?
Caplight tracks bids, offers, and trades in Evaran's shares on secondary markets.